{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:37:09Z","timestamp":1792791429652,"version":"4.5.0"},"reference-count":81,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2025,3,24]],"date-time":"2025-03-24T00:00:00Z","timestamp":1742774400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Brazilian research agencies","award":["RED-00198-23"],"award-info":[{"award-number":["RED-00198-23"]}]},{"name":"Brazilian research agencies","award":["APQ-01313-14"],"award-info":[{"award-number":["APQ-01313-14"]}]},{"name":"Brazilian research agencies","award":["312201\/2021-4"],"award-info":[{"award-number":["312201\/2021-4"]}]},{"name":"Brazilian research agencies","award":["INCT-Toxo 406572\/2022-4"],"award-info":[{"award-number":["INCT-Toxo 406572\/2022-4"]}]},{"name":"Brazilian research agencies","award":["AUXPE-02450\/09-7"],"award-info":[{"award-number":["AUXPE-02450\/09-7"]}]},{"name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico (CNPq, Brazil)","award":["RED-00198-23"],"award-info":[{"award-number":["RED-00198-23"]}]},{"name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico (CNPq, Brazil)","award":["APQ-01313-14"],"award-info":[{"award-number":["APQ-01313-14"]}]},{"name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico (CNPq, Brazil)","award":["312201\/2021-4"],"award-info":[{"award-number":["312201\/2021-4"]}]},{"name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico (CNPq, Brazil)","award":["INCT-Toxo 406572\/2022-4"],"award-info":[{"award-number":["INCT-Toxo 406572\/2022-4"]}]},{"name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico (CNPq, Brazil)","award":["AUXPE-02450\/09-7"],"award-info":[{"award-number":["AUXPE-02450\/09-7"]}]},{"name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior-CAPES","award":["RED-00198-23"],"award-info":[{"award-number":["RED-00198-23"]}]},{"name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior-CAPES","award":["APQ-01313-14"],"award-info":[{"award-number":["APQ-01313-14"]}]},{"name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior-CAPES","award":["312201\/2021-4"],"award-info":[{"award-number":["312201\/2021-4"]}]},{"name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior-CAPES","award":["INCT-Toxo 406572\/2022-4"],"award-info":[{"award-number":["INCT-Toxo 406572\/2022-4"]}]},{"name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior-CAPES","award":["AUXPE-02450\/09-7"],"award-info":[{"award-number":["AUXPE-02450\/09-7"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Microorganisms"],"abstract":"<jats:p>Toxoplasmosis is a globally prevalent zoonotic parasitic disease. Neonates with congenital infection can develop severe long-term sequelae, which can be mitigated or prevented through early diagnosis and therapeutic approaches. In this context, the main objective of this study was to describe the main treatments and evaluate the effectiveness of the current treatment protocols for gestational and congenital toxoplasmosis to prevent vertical transmission and to reduce clinical manifestations in neonates. This systematic review with a meta-analysis searched digital databases (PUBMED, SCOPUS, WEB OF SCIENCE, EMBASE, and COCHRANE) for observational cohort studies published between 1 January 2013 and 29 January 2025, evaluating treatment effectiveness in gestational and congenital toxoplasmosis. Risk ratios (RRs) were calculated using random effects models to assess infection risk and clinical manifestations in neonates. The study quality was assessed following the Joanna Briggs Institute protocol and fifty-six studies from 16 countries were included, comprising 11,090 pregnant women and 4138 children. Studies were predominantly from Brazil (38%), France, and Italy. Only 9% of the studies indicated knowledge of the serological status of the pregnant woman before the gestational stage. Of 10,148 women with confirmed toxoplasmosis, 8600 received treatment, with 18% of their children infected, compared to a 58% infection rate in untreated mothers\u2019 children. Meta-analysis showed that treatment reduced infection risk (RR = 0.34 [0.21; 0.57]) and clinical manifestations (RR = 0.30 [0.17; 0.56]). While spiramycin or triple therapy showed similar effects, triple therapy demonstrated more consistent results (RR: 0.22 [0.15; 0.32]) compared to spiramycin alone (RR: 0.54 [0.06; 4.67]). In conclusion, treatment protocols for congenital or gestational toxoplasmosis have proven to be effective in reducing the risk of infection and clinical manifestations in neonates. Regarding the type of treatment, although they have similar responses, the use of triple therapy shows more consistent responses than isolated spiramycin. It can be also concluded that prevention and mitigation of congenital toxoplasmosis require standardized treatment protocols, improved diagnostic methods, and educational programs for women of childbearing age, as treatment initiation timing and protocol choice are crucial factors in determining outcomes.<\/jats:p>","DOI":"10.3390\/microorganisms13040723","type":"journal-article","created":{"date-parts":[[2025,3,25]],"date-time":"2025-03-25T06:25:15Z","timestamp":1742883915000},"page":"723","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Treatment Protocols for Gestational and Congenital Toxoplasmosis: A Systematic Review and Meta-Analysis"],"prefix":"10.3390","volume":"13","author":[{"given":"Sissi Kelly","family":"Ribeiro","sequence":"first","affiliation":[{"name":"Laboratory of Immunoparasitology, Institute of Biomedical Sciences, Federal University of Uberl\u00e2ndia, Uberl\u00e2ndia 38400-678, MG, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8691-8669","authenticated-orcid":false,"given":"Igor Moraes","family":"Mariano","sequence":"additional","affiliation":[{"name":"Laboratory of Cardiorespiratory and Metabolic Physiology, Federal University of Uberl\u00e2ndia, Uberl\u00e2ndia 38405-302, MG, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Clara Ribeiro","family":"Cunha","sequence":"additional","affiliation":[{"name":"Laboratory of Cardiorespiratory and Metabolic Physiology, Federal University of Uberl\u00e2ndia, Uberl\u00e2ndia 38405-302, MG, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Cl\u00e1udia Arantes Marquez","family":"Pajuaba","sequence":"additional","affiliation":[{"name":"Laboratory of Immunoparasitology, Institute of Biomedical Sciences, Federal University of Uberl\u00e2ndia, Uberl\u00e2ndia 38400-678, MG, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2339-2743","authenticated-orcid":false,"given":"Tiago Wilson Patriarca","family":"Mineo","sequence":"additional","affiliation":[{"name":"Laboratory of Immunoparasitology, Institute of Biomedical Sciences, Federal University of Uberl\u00e2ndia, Uberl\u00e2ndia 38400-678, MG, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9010-7228","authenticated-orcid":false,"given":"Jos\u00e9 Roberto","family":"Mineo","sequence":"additional","affiliation":[{"name":"Laboratory of Immunoparasitology, Institute of Biomedical Sciences, Federal University of Uberl\u00e2ndia, Uberl\u00e2ndia 38400-678, MG, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,3,24]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1007\/s10393-019-01405-7","article-title":"The One Health Approach to Toxoplasmosis: Epidemiology, Control, and Prevention Strategies","volume":"16","author":"Aguirre","year":"2019","journal-title":"Ecohealth"},{"key":"ref_2","first-page":"2","article-title":"Atypical strains of Toxoplasma gondii and its impact on development of toxoplasmosis","volume":"12","author":"Vieira","year":"2023","journal-title":"Res. Soc. Dev."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Kamus, L., Belec, S., Lambrecht, L., Abasse, S.L., Olivier, S., Combe, P.L., Bonnave, P.-E., Vauloup-Fellous, C.L., and Jaffe, C. (2023). Maternal and congenital toxoplasmosis in Mayotte: Prevalence, incidence and management. PLoS Negl. Trop. Dis., 17.","DOI":"10.1371\/journal.pntd.0011198"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1186\/s40001-021-00606-7","article-title":"A fresh look at the role of spiramycin in preventing a neglected disease: Meta-analyses of observational studies","volume":"26","author":"Montoya","year":"2021","journal-title":"Eur. J. Med. Res."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"e00036","DOI":"10.1016\/j.fawpar.2019.e00036","article-title":"Treatment of toxoplasmosis: Current options and future perspectives","volume":"15","author":"Konstantinovic","year":"2019","journal-title":"Food Waterborne Parasitol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"111711","DOI":"10.1016\/j.ejmech.2019.111711","article-title":"Recent progress on anti-Toxoplasma drugs discovery: Design, synthesis and screening","volume":"183","author":"Deng","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"ref_7","first-page":"811","article-title":"Effect of Antenatal Treatment on the Severity of Congenital Toxoplasmosis","volume":"62","author":"Wallon","year":"2015","journal-title":"Clin. Infect. Dis."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"e00057-17","DOI":"10.1128\/CMR.00057-17","article-title":"Treatment of Toxoplasmosis: Historical Perspective, Animal Models, and Current Clinical Practice","volume":"31","author":"Dunay","year":"2018","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"273","DOI":"10.2147\/DDDT.S60973","article-title":"Drugs in development for toxoplasmosis: Advances, challenges, and current status","volume":"11","author":"Alday","year":"2017","journal-title":"Drug Des. Devel. Ther."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"109376","DOI":"10.1016\/j.mehy.2019.109376","article-title":"Adjunctive bradyzoite-directed therapy for reducing complications of congenital toxoplasmosis","volume":"133","author":"Chorlton","year":"2019","journal-title":"Med. Hypotheses"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Dos Santos, D.A., Souza, H.F.S., Silber, A.M., Souza, T.D.A.C.B.D., and \u00c1vila, A.R. (2023). Protein kinases on carbon metabolism: Potential targets for alternative chemotherapies against toxoplasmosis. Front. Cell. Infect. Microbiol., 13.","DOI":"10.3389\/fcimb.2023.1175409"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s13643-021-01626-4","article-title":"The PRISMA 2020 statement: An updated guideline for reporting systematic reviews","volume":"10","author":"Page","year":"2021","journal-title":"Syst. Rev."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/s13643-016-0384-4","article-title":"Rayyan\u2014A web and mobile app for systematic reviews","volume":"5","author":"Ouzzani","year":"2016","journal-title":"Syst. Rev."},{"key":"ref_14","unstructured":"The Joanna Briggs (2015). The Joanna Briggs Institute Reviewers\u2019. Manual 2015: Methodology for JBI Scoping Reviews, Joanne Briggs Institute."},{"key":"ref_15","unstructured":"R Core Team (2025, February 10). R: A Language and Environment for Statistical Computing [Internet]. Vienna R Foundation for Statistical Computing. Available online: https:\/\/www.r-project.org."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1136\/ebmental-2019-300117","article-title":"How to perform a meta-analysis with R: A practical tutorial","volume":"22","author":"Balduzzi","year":"2019","journal-title":"Evid. Based Ment. Health"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v036.i03","article-title":"Conducting meta-analyses in R with the metafor package","volume":"36","author":"Viechtbauer","year":"2010","journal-title":"J. Stat. Softw."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/j.1467-985X.2008.00552.x","article-title":"A re-evaluation of random-effects meta-analysis","volume":"172","author":"Higgins","year":"2009","journal-title":"J. R. Stat. Soc. Ser. A Stat. Soc."},{"key":"ref_19","first-page":"238","article-title":"Prevention of congenital toxoplasmosis in a Buenos Aires hospital","volume":"73","author":"Carral","year":"2013","journal-title":"Medicina"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Damar \u00c7ak\u0131rca, T., Can, \u0130.N., Deniz, M., Torun, A., Ak\u00e7abay, \u00c7., and G\u00fczel\u00e7i\u00e7ek, A. (2023). Toxoplasmosis: A Timeless Challenge for Pregnancy. Trop. Med. Infect. Dis., 8.","DOI":"10.3390\/tropicalmed8010063"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1051\/parasite\/2019013","article-title":"Toxoplasmose cong\u00e9nitale aux \u00c9tats-Unis: Observations cliniques et s\u00e9rologiques chez les nourrissons n\u00e9s de m\u00e8res trait\u00e9es pendant la grossesse","volume":"26","author":"Olariu","year":"2019","journal-title":"Parasite"},{"key":"ref_22","first-page":"191.e1","article-title":"Amniocentesis for the detection of congenital toxoplasmosis: Results from the nationwide Austrian prenatal screening program","volume":"21","author":"Prusa","year":"2015","journal-title":"Clin. Microbiol. Infect. Off. Publ. Eur. Soc. Clin. Microbiol. Infect. Dis."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"E223","DOI":"10.1097\/INF.0000000000003469","article-title":"Spyramicine and Trimethoprim-Sulfamethoxazole Combination to Prevent Mother-To-Fetus Transmission of Toxoplasma gondii Infection in Pregnant Women: A 28-Years Single-center Experience","volume":"41","author":"Buonsenso","year":"2022","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1016\/j.ophtha.2021.03.009","article-title":"Ocular Findings in Infants with Congenital Toxoplasmosis after a Toxoplasmosis Outbreak","volume":"128","author":"Belucik","year":"2021","journal-title":"Ophthalmology"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"108859","DOI":"10.1016\/j.clim.2021.108859","article-title":"Long-term impact of congenital toxoplasmosis on phenotypic and functional features of circulating leukocytes from infants one year after treatment onset","volume":"232","author":"Gomes","year":"2021","journal-title":"Clin. Immunol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12884-017-1300-1","article-title":"Management of suspected primary Toxoplasma gondii infection in pregnant women in Norway: Twenty years of experience of amniocentesis in a low-prevalence population","volume":"17","author":"Findal","year":"2017","journal-title":"BMC Pregnancy Childbirth"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"e01368-20","DOI":"10.1128\/JCM.01368-20","article-title":"Maternal Anti-Toxoplasma Treatment during Pregnancy Is Associated with Reduced Sensitivity of Diagnostic Tests for Congenital Infection in the Neonate","volume":"59","author":"Guegan","year":"2021","journal-title":"J. Clin. Microbiol."},{"key":"ref_28","first-page":"603","article-title":"Toxoplasma gondii infection during pregnancy: A ten-year observation in the province of Trento, Italy","volume":"28","author":"Piffer","year":"2020","journal-title":"Le Infez. Med."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1097\/INF.0b013e3182343096","article-title":"Severe congenital toxoplasmosis in the United States: Clinical and serologic findings in untreated infants","volume":"30","author":"Olariu","year":"2011","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"e20220225","DOI":"10.1590\/1806-9304202300000225","article-title":"Profile of pregnant women and children accompanied due to T. gondii exposure at a referred healthcare center: What has changed in 10 years?","volume":"23","author":"Soares","year":"2023","journal-title":"Rev. Bras. Saude Matern. Infant."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/jp.2014.161","article-title":"Spiramycin\/cotrimoxazole versus pyrimethamine\/sulfonamide and spiramycin alone for the treatment of toxoplasmosis in pregnancy","volume":"35","author":"Valentini","year":"2015","journal-title":"J. Perinatol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.jiac.2019.01.009","article-title":"A cohort study of maternal screening for congenital Toxoplasma gondii infection: 12 years\u2019 experience","volume":"25","author":"Yamada","year":"2019","journal-title":"J. Infect. Chemother."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.ejogrb.2021.11.019","article-title":"Primary toxoplasmosis acquired during early pregnancy: Is it currently overestimated?","volume":"267","author":"Trotta","year":"2021","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1128\/JCM.00169-13","article-title":"Toxoplasma seroconversion with negative or transient immunoglobulin M in pregnant women: Myth or reality? A French multicenter retrospective study","volume":"51","author":"Cimon","year":"2013","journal-title":"J. Clin. Microbiol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"3746","DOI":"10.1080\/14767058.2019.1583737","article-title":"Congenital toxoplasmosis and proposal of a new classification for the likelihood of primary maternal infection: Analysis of 375 cases in Southeast Italy","volume":"33","author":"Vimercati","year":"2020","journal-title":"J. Matern. Neonatal Med."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1093\/cid\/cit032","article-title":"Congenital toxoplasma infection: Monthly prenatal screening decreases transmission rate and improves clinical outcome at age 3 years","volume":"56","author":"Wallon","year":"2013","journal-title":"Clin. Infect. Dis."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.jiac.2021.12.005","article-title":"A prospective cohort study of newborns born to mothers with serum Toxoplasma gondii immunoglobulin M positivity during pregnancy","volume":"28","author":"Hijikata","year":"2022","journal-title":"J. Infect. Chemother."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Gomes-Ferrari-Strang, A.G., Ferrar, R.G., and Falavigna-Guilherme, A.L. (2023). Gestational toxoplasmosis treatment changes the child\u2019s prognosis: A cohort study in southern Brazil. PLoS Negl. Trop. Dis., 17.","DOI":"10.1371\/journal.pntd.0011544"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"e40108","DOI":"10.15448\/1980-6108.2021.1.40108","article-title":"Epidemiological profile of gestational and congenital toxoplasmosis cases arising out of the population outbreak","volume":"31","author":"Righi","year":"2021","journal-title":"Sci. Med."},{"key":"ref_40","first-page":"46","article-title":"Psychometric properties of CVFQ7-BR-toxo to evaluate vision-related quality of life in children with congenital toxoplasmosis in Brazil","volume":"85","author":"Vasconcelos","year":"2022","journal-title":"Arq. Bras. Oftalmol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1016\/j.jogc.2020.04.021","article-title":"Treatment of Acute Toxoplasmosis in Pregnancy: Influence in the Mother-to-Child Transmission","volume":"42","author":"Bartholo","year":"2020","journal-title":"J. Obstet. Gynaecol. Can."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.3109\/14767058.2015.1074998","article-title":"Role of spiramycin in prevention of fetal toxoplasmosis","volume":"29","author":"Avci","year":"2016","journal-title":"J. Matern. Neonatal Med."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.ajog.2018.05.031","article-title":"Prenatal therapy with pyrimethamine plus sulfadiazine vs spiramycin to reduce placental transmission of toxoplasmosis: A multicenter, randomized trial","volume":"219","author":"Mandelbrot","year":"2018","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Avelino, M.M., Amaral, W.N., Rodrigues, I.M., Rassi, A.R., Gomes, M.B., Costa, T.L., and Castro, A.M. (2014). Congenital toxoplasmosis and prenatal care state programs. BMC Infect. Dis., 14.","DOI":"10.1186\/1471-2334-14-33"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1111\/tmi.14021","article-title":"The prevention of congenital toxoplasmosis using a combination of Spiramycin and Cotrimoxazole: The long-time experience of a tertiary referral centre","volume":"29","author":"Tartaglia","year":"2024","journal-title":"Trop. Med. Int. Health"},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Guarch-Ib\u00e1\u00f1ez, B., Carreras-Abad, C., Frick, M.A., Bl\u00e1zquez-Gamero, D., Baquero-Artigao, F., and Fuentes, I. (2024). REIV-TOXO Project: Results from a Spanish cohort of congenital toxoplasmosis (2015\u20132022). The beneficial effects of prenatal treatment on clinical outcomes of infected newborns. PLoS Neglected Trop. Dis., 18.","DOI":"10.1371\/journal.pntd.0012619"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.jped.2013.12.006","article-title":"Presence and duration of anti-Toxoplasma gondii immunoglobulin M in infants with congenital toxoplasmosis","volume":"90","author":"Lago","year":"2014","journal-title":"J. Pediatr."},{"key":"ref_48","first-page":"e52971","article-title":"Congenital Toxoplasmosis Diagnosis: Challenges and Management Outcomes","volume":"16","author":"Losa","year":"2024","journal-title":"Cureus"},{"key":"ref_49","first-page":"100010","article-title":"Evaluation of the impact of the first evidence-based guidelines for congenital toxoplasmosis in Armenia (Quind\u00edo) Colombia: An observational retrospective analysis","volume":"1","year":"2021","journal-title":"Lancet Reg. Health\u2014Am."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"e4","DOI":"10.1093\/cid\/ciu724","article-title":"The Austrian toxoplasmosis register, 1992\u20132008","volume":"60","author":"Prusa","year":"2015","journal-title":"Clin. Infect. Dis."},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Rodrigues, I.M., Costa, T.L., Avelar, J.B., Amaral, W.N., Castro, A.M., and Avelino, M.M. (2014). Assessment of laboratory methods used in the diagnosis of congenital toxoplasmosis after maternal treatment with spiramycin in pregnancy. BMC Infect. Dis., 14.","DOI":"10.1186\/1471-2334-14-349"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s40124-022-00269-w","article-title":"Building Programs to Eradicate Toxoplasmosis Part I: Introduction and Overview","volume":"10","author":"Wang","year":"2022","journal-title":"Curr. Pediatr. Rep."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.ijpara.2003.11.024","article-title":"Use of molecular and ultrastructural markers to evaluate stage conversion of Toxoplasma gondii in both the intermediate and definitive host","volume":"34","author":"Ferguson","year":"2004","journal-title":"Int. J. Parasitol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1097\/INF.0000000000002931","article-title":"Ocular Outcome of Brazilian Patients with Congenital Toxoplasmosis","volume":"40","author":"Lago","year":"2021","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"e601","DOI":"10.1542\/peds.2013-2153","article-title":"Ophthalmic outcomes of congenital toxoplasmosis followed until adolescence","volume":"133","author":"Wallon","year":"2014","journal-title":"Pediatrics"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1007\/s40124-014-0055-7","article-title":"Management of Congenital Toxoplasmosis","volume":"2","author":"McLeod","year":"2014","journal-title":"Curr. Pediatr. Rep."},{"key":"ref_57","unstructured":"World Health Organization (2007). Promoting Safety of Medicines for Children, WHO Press."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"332","DOI":"10.5578\/flora.69026","article-title":"Results of the Toxoplasmosis Screening in 9311 Pregnant Women in a Tertiary Center in Turkey","volume":"25","author":"Kan","year":"2020","journal-title":"Flora"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"296","DOI":"10.18621\/eurj.1039212","article-title":"Toxoplasmosis in pregnancy: Test, treatment and outcome","volume":"8","author":"Kalem","year":"2022","journal-title":"Eur. Res. J."},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Montazeri, M., Mehrzadi, S., Sharif, M., Sarvi, S., Tanzifi, A., Aghayan, S.A., and Daryani, A. (2018). Drug Resistance in Toxoplasma gondii. Front. Microbiol., 9.","DOI":"10.3389\/fmicb.2018.02587"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1186\/s13071-023-06080-w","article-title":"Genetic diversity of Toxoplasma gondii in South America: Occurrence, immunity, and fate of infection","volume":"16","author":"Brito","year":"2023","journal-title":"Parasites Vectors"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"593","DOI":"10.12891\/ceog4585.2019","article-title":"Polymerase chain reaction analysis of amniotic fluid for diagnosis of fetal toxoplasmosis","volume":"46","author":"Andrade","year":"2019","journal-title":"Clin. Exp. Obstet. Gynecol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.4269\/ajtmh.17-0580","article-title":"Congenital toxoplasmosis in Tunisia: Prenatal and neonatal diagnosis and postnatal follow-up of 35 cases","volume":"98","author":"Boudaouara","year":"2018","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"269","DOI":"10.3166\/bspe-2019-0054","article-title":"Management of Toxoplasmic Seroconversion in the Third Trimester of Pregnancy in Tunisia","volume":"111","author":"Bouhlel","year":"2018","journal-title":"Bull. De La Soc. De Pathol. Exot. (1990)"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.bjid.2013.11.009","article-title":"Congenital toxoplasmosis in a reference center of Paran\u00e1, Southern Brazil","volume":"18","author":"Capobiango","year":"2014","journal-title":"Braz. J. Infect. Dis."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1097\/INF.0000000000001561","article-title":"High Frequency of Bone Marrow Depression During Congenital Toxoplasmosis Therapy in a Cohort of Children Identified By Neonatal Screening in Minas Gerais, Brazil","volume":"36","author":"Carellos","year":"2017","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref_67","first-page":"25","article-title":"Evaluation of the avidity test for the follow up on children treated for congenital toxoplasmosis during the first year of life","volume":"34","year":"2021","journal-title":"Iatreia"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"105455","DOI":"10.1016\/j.micpath.2022.105455","article-title":"Delta-aminolevulinate dehydratase enzyme activity and the oxidative profile of pregnant women being treated for acute toxoplasmosis","volume":"164","author":"Vendrame","year":"2022","journal-title":"Microb. Pathog."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1055\/s-0039-1697034","article-title":"Follow-up of Toxoplasmosis during Pregnancy: Ten-Year Experience in a University Hospital in Southern Brazil","volume":"41","author":"Diesel","year":"2019","journal-title":"Rev. Bras. Ginecol. Obstet."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.ejogrb.2019.07.033","article-title":"Incidence of toxoplasmosis in pregnancy in Campania: A population-based study on screening, treatment, and outcome","volume":"240","author":"Donadono","year":"2019","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s10096-021-04337-9","article-title":"Association between lymphadenopathy after toxoplasmosis seroconversion in pregnancy and risk of congenital infection","volume":"41","author":"Donadono","year":"2022","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1590\/s1678-9946202062046","article-title":"Prospective evalution of pregnant women with suspected acute toxoplasmosis treated in a reference prenatal care clinic at a university teaching hospital in Southern Brazil","volume":"62","author":"Evangelista","year":"2020","journal-title":"Rev. Inst. Med. Trop. Sao Paulo"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"105145","DOI":"10.1016\/j.meegid.2021.105145","article-title":"Molecular detection of Toxoplasma gondii in placentas of women who received therapy during gestation in a toxoplasmosis outbreak","volume":"97","author":"Ludwig","year":"2022","journal-title":"Infect. Genet. Evol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"fmaa069","DOI":"10.1093\/tropej\/fmaa069","article-title":"Congenital Toxoplasmosis: Missed Opportunities for Diagnosis and Prevention","volume":"67","author":"Mueller","year":"2021","journal-title":"J. Trop. Pediatr."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1179\/2046905514Y.0000000149","article-title":"Congenital toxoplasmosis: An uncommon disease in Thailand","volume":"35","author":"Pengsaa","year":"2015","journal-title":"Paediatr. Int. Child Health"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"2215377","DOI":"10.1080\/14767058.2023.2215377","article-title":"Comparison of adverse reactions of spiramycin versus pyrimethamine\/sulfadiazine treatment of toxoplasmosis in pregnancy: Is spiramycin really the drug of choice for unproven infection of the fetus?","volume":"36","author":"Prasil","year":"2023","journal-title":"J. Matern.-Fetal Neonatal Med."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jpp.2013.01.004","article-title":"La toxoplasmose cong\u00e9nitale: \u00e0 propos de 21 cas","volume":"26","author":"Saghrouni","year":"2013","journal-title":"J. P\u00e9diatr. Pu\u00e9ricult."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1097\/INF.0000000000001120","article-title":"Treatment of Congenital Toxoplasmosis: Safety of the Sulfadoxine-Pyrimethamine Combination in Children Based on a Method of Causality Assessment","volume":"35","author":"Teil","year":"2016","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.bjid.2020.10.001","article-title":"Toxoplasmosis in pregnancy: A clinical, diagnostic, and epidemiological study in a referral hospital in Rio de Janeiro, Brazil","volume":"24","author":"Villar","year":"2020","journal-title":"Braz. J. Infect. Dis."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1097\/AOG.0000000000002131","article-title":"Association of Parasite Load Levels in Amniotic Fluid With Clinical Outcome in Congenital Toxoplasmosis","volume":"130","author":"Yamamoto","year":"2017","journal-title":"Obstet. Gynecol."},{"key":"ref_81","first-page":"86","article-title":"Effect of antenatal spiramycin treatment on the frequency of retinochoroiditis due to congenital toxoplasmosis in a Colombian cohort","volume":"37","author":"Zuluaga","year":"2017","journal-title":"Biomedica"}],"container-title":["Microorganisms"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-2607\/13\/4\/723\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:59:06Z","timestamp":1760029146000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-2607\/13\/4\/723"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,24]]},"references-count":81,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,4]]}},"alternative-id":["microorganisms13040723"],"URL":"https:\/\/doi.org\/10.3390\/microorganisms13040723","relation":{},"ISSN":["2076-2607"],"issn-type":[{"value":"2076-2607","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,24]]}}}